Shire launches non-calcium hyperphosphataemia treatment

摘要

Lanthanum carbonate,a non-calcium binding agent for controlling hyperphosphataemia,has been launched by Shire.Marketed as Fosrenol,lanthanum carbonate is indicated for use as a phosphate-binding agent to control hyperphosphataemia in patients with chronic renal disease on haemodial-ysis or continuous peritoneal dialysis.